Mounjaro top tips that actually come from the evidence

What the SURMOUNT trial data tells us about lifestyle pairing

The headline weight-loss figures from SURMOUNT-1 (published in the New England Journal of Medicine) came from participants who also followed a reduced-calorie diet and increased their physical activity. That pairing was baked into the trial design, not optional. The medicine quietens appetite substantially; the lifestyle changes direct that quietened appetite toward steady, sustainable results rather than just eating less of the same food.

In practical terms this means that the first weeks on the starter dose are a useful window. Your appetite may still be broadly normal at 2.5 mg, that dose is calibrated to let your system settle rather than to produce immediate weight changes. Use that period to build habits: a regular walk, a rough daily protein target, a meal pattern your prescriber knows about. When appetite does fall more noticeably at higher doses, those habits are already in place.

Protein deserves a specific mention. As appetite drops, total calorie intake falls, and with it the risk of losing muscle alongside fat. Most people find that consciously including a protein source at every meal (eggs, fish, legumes, Greek yoghurt) helps preserve muscle mass and reduces fatigue. The NHS Live Well guidance on healthy weight covers practical diet basics that translate well to life on GLP-1 treatment.

Managing the GI side effects that most people face early on

Nausea is the side effect our prescribers are asked about most. It shows up most often in the first few days after starting or after a dose step up, then usually fades. A few things make a consistent difference.

Meal size matters more than meal content at this stage. Large portions push on a stomach that is already emptying more slowly than usual; smaller portions eaten more slowly tend to cause far less discomfort. Fatty or very rich meals amplify nausea for most people, so temporarily dialling those back helps. Plain water sipped throughout the day rather than drunk in large quantities at once also reduces the likelihood of feeling sick.

Constipation is the other common early complaint. Fibre and fluid are the straightforward answer, both often drop when appetite falls and overall food intake decreases. If symptoms are significant or persistent, that is worth mentioning to your prescriber rather than managing alone. And if nausea or vomiting is severe and not settling, your prescriber needs to know: dehydration from persistent vomiting can affect kidney function. The NHS tirzepatide page lists the full side-effect profile and the signs that need prompt attention.

Injection technique: the details that affect how comfortably the medicine works

Mounjaro is injected subcutaneously (into the fat just beneath the skin) once a week. Three sites work: the abdomen (at least a few centimetres from the navel), the outer thigh, and the upper arm. Rotating between sites each week reduces the chance of skin changes at any one spot, and rotating within each area does too. A small circle of sites rather than the same patch repeatedly is worth building into your routine.

Temperature matters more than people expect. Mounjaro is stored in the fridge at 2–8°C; injecting a cold pen can sting. Taking the pen out 30 minutes before your injection and letting it reach room temperature makes the injection noticeably more comfortable for most people. The exact window for which it can safely sit at room temperature is stated in the Patient Information Leaflet, always check that rather than guessing. Your pen arrives from our pharmacy via DPD the next working day in plain, unbranded packaging, with the cold chain maintained; it goes straight into the fridge door when it lands.

Pick a day of the week that works for you and keep to it. If you genuinely cannot inject on your usual day, the guidance on flexibility is in the leaflet and in the hands of your prescriber, not something to estimate. For more on the practical side of using the KwikPen, our tips for taking Mounjaro cover everything from preparing your pen to what to do if you miss a dose, and our guide to using Mounjaro goes into further detail.

Contraception, other medicines, and things worth discussing before you start

One finding from the clinical safety data that catches some people off guard: tirzepatide slows gastric emptying, which can reduce how much of an oral contraceptive pill is absorbed. The MHRA advises that women using the pill add a non-oral method of contraception (condoms, for instance) for the first four weeks of treatment and for four weeks after each dose increase. This applies specifically to tirzepatide; speaking to our prescribers before you start is the right time to go through this and any other medicines you take regularly.

HRT is worth a brief mention for the same reason: NHS England advises considering a transdermal form of HRT (patches or gels) while taking tirzepatide, because absorbed-through-the-skin options sidestep the gastric-emptying issue. Again, your prescriber or GP is the person to discuss that with before making any changes.

Surgery is a less common but important scenario. If any planned procedure is on the horizon, your anaesthetist needs to know you are taking Mounjaro; slowed gastric emptying affects anaesthesia risk. There is broader reading on safety considerations, alongside Mounjaro tips covering common questions our prescribers hear, on our Mounjaro tips for weight loss page. For a fuller picture of what tirzepatide is and how it works, the tirzepatide overview on our site is a good starting point, and if you want practical guidance on getting the most from your treatment, our tirzepatide tips are worth reading alongside it; NICE's recommendation (TA1026) sets out the evidence base the medicine was approved on. If you are ready to check whether you meet the eligibility criteria, check your eligibility with our clinical team.